Patents by Inventor Peter A. Hevezi

Peter A. Hevezi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040259152
    Abstract: Described herein are methods that can be used for diagnosis of tissue remodeling, as well as tissue remodeling phenotypes. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate tissue remodeling. Additionally, molecular targets (genes and their products) for therapeutic intervention in disorders associated with tissue remodeling are described. Moreover, methods for using such molecular targets are described.
    Type: Application
    Filed: August 5, 2003
    Publication date: December 23, 2004
    Inventors: Richard Murray, Susan Watson, Stephen J. Weiss, Richard Glynne, Peter Hevezi
  • Publication number: 20040009494
    Abstract: Described herein are methods that can be used for diagnosis of angiogenesis and angiogenic phenotypes. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate angiogenesis. Additionally, molecular targets (genes and their products) for therapeutic intervention in disorders associated with angiogenesis are described. Moreover, methods for using such molecular targets are described.
    Type: Application
    Filed: November 20, 2002
    Publication date: January 15, 2004
    Inventors: Richard Murray, Susan Watson, Stephen J. Weiss, Richard Glynne, Peter Hevezi
  • Publication number: 20030232350
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in specific cancers or other diseases, or are otherwise regulated in disease. Related methods and compositions that can be used for diagnosis, prognosis, and treatment of those medical conditions are disclosed. Also described herein are methods that can be used to identify modulators of these selected conditions.
    Type: Application
    Filed: November 13, 2002
    Publication date: December 18, 2003
    Applicant: Eos Biotechnology, Inc.
    Inventors: Daniel Afar, Natasha Aziz, Wendy M. Ginsburg, Kurt C. Gish, Richard Glynne, Peter A. Hevezi, David H. Mack, Richard Murray, Susan R. Watson, Keith E. Wilson, Albert Zlotnik
  • Publication number: 20030049722
    Abstract: The invention relates to the identification of nucleic acids and expression profiles involved in destructive macrophage (DM) development, and to the use of such expression profiles and nucleic acids in methods for identifying candidate agents which modulate this development.
    Type: Application
    Filed: March 15, 2000
    Publication date: March 13, 2003
    Inventors: Richard Murray, Ingrid W. Caras, Peter Hevezi, Keith Wilson
  • Publication number: 20020068036
    Abstract: Described herein are methods that can be used for diagnosis and prognosis of prostate cancer and/or breast cancer. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate prostate cancer and/or breast cancer. Additionally, methods and molecular targets (genes and their products) for therapeutic intervention in prostate cancer, breast cancer and other cancers are described.
    Type: Application
    Filed: April 30, 2001
    Publication date: June 6, 2002
    Applicant: EOS BIOTECHNOLOGY, INC.
    Inventors: Peter Hevezi, David Mack, Kurt C. Gish, Keith E. Wilson
  • Publication number: 20020019330
    Abstract: Described herein are methods that can be used for diagnosis of angiogenesis and angiogenic phenotypes. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate angiogenesis. Additionally, molecular targets (genes and their products) for therapeutic intervention in disorders associated with angiogenesis are described. Moreover, methods for using such molecular targets are described.
    Type: Application
    Filed: December 15, 2000
    Publication date: February 14, 2002
    Inventors: Richard Murray, Susan Watson, Stephen J. Weiss, Richard Glynne, Peter Hevezi
  • Publication number: 20020015970
    Abstract: Described herein are methods that can be used for diagnosis of angiogenesis and angiogenic phenotypes. Also described herein are methods that can be used to screen candidate bioactive agents for the ability to modulate angiogenesis. Additionally, molecular targets (genes and their products) for therapeutic intervention in disorders associated with angiogenesis are described. Moreover, methods for using such molecular targets are described.
    Type: Application
    Filed: December 15, 2000
    Publication date: February 7, 2002
    Inventors: Richard Murray, Susan Watson, Stephen J. Weiss, Richard Glynne, Peter Hevezi